Generate Professional PDF Documents and Easily Keep them Up-to-Date
OS: Windows 7 or later. MacOS 10.10 or later. Fedora Linux 21 or later. Red Hat Linux 7.2 or later. Ubuntu Linux 14.04 or later. Memory: 1 GB RAM: Hard Disk: 250 MB available disk space. The 1.2 version of Pronto Patent for Mac is available as a free download on our website. The actual developer of this free software for Mac is Gracion Software. The application lies within Business Tools, more precisely Legal. Mac Game Compatibility Checker™ Ever purchase a game but only later learn it's not compatible with your Mac? The MacGameStore app's built-in Compatibility Checker compares your Mac to the game's system requirements in real-time. Don't waste your money on games that won't work on your Mac. ACPAA - Locating Chinese patent agencies using agency codes (PDF, 1.3 MB) CNIPA - Legal status search in Chinese (PDF, 863 KB) CNIPA - Online file inspection in the CPQUERY database (PDF, 621 KB) CNIPA - Searching re-examination and invalidation decisions (PDF, 906 KB) CNIPA - Retrieving online gazette issues (PDF, 480 KB). The free ProtonVPN plan is the only free VPN that does not run privacy-invading ads, throttle your bandwidth, or sell your data to third parties. P2P Support Unlimited Bandwidth 10Gbit Servers Up to 10 Devices Professional Support.
Volume Licensing
Features
Edit PDF Text
PDF Editor for Mac allows users to add and edit text and image objects in PDF files, and enable users to change text formats including font type, style, size, color, text alignment, etc.
Integrate with Popular Enterprise CMS
Check in and check out PDFs from iManage WorkSite and SharePoint.
Add Headers, Footers, and Watermarks
PDF Editor for Mac allows users to add, edit, or delete headers, footers, watermarks and backgrounds in a PDF file.
Create and Export PDF
PDF Editor for Mac allows users to convert Microsoft Office, HTML, image, and text files to PDF, PDF/A, PDF/E, and PDF/X. Create, view, print, edit, and search for text in PDF portfolios.
Export PDF content to Microsoft Office, HTML, image, and text files.
Optimize PDF Files
Optimize PDF files to reduce file size by compressing images, and clearing out redundant PDF objects, user data and unembedded fonts.
Scan and OCR
Many times hardcopy documents are required to be in digital format. PhantomPDF Mac is the PDF Editor that provides capabilities to support your paperless office workflows.
Interfaces with your scanner to scan and convert to PDF documents. Will convert existing scans (i.e. images) to PDF.
OCRs image based content into selectable and searchable text. OCR (Optical Character Recognition) identifies characters and words within images.
OCR option to make PDF text editable, which is really valuable when updating documents when you only have the hardcopy.
Organize PDF Files and Pages
PDF Editor for Mac allows users to insert and merge PDF documents together or split PDF apart. Delete, extract, duplicate, replace, or rotate pages to reorganize PDF documents. Compare two PDF documents and highlight the differences to help you identify what has been changed quickly and easily.
PhantomPDF Articles allow you to define a navigational path (or an article thread) for an article in a PDF document that spans multiple columns and/or across several pages. Jurassic park theme piano sheet music free pdf.
Work with PDF Forms
Create PDF forms quickly and easily with automated form field recognition and designer assistant. Create professional looking forms with push and radio buttons; check, combo, and list boxes; and text and signature fields.
Users can also open and fill XFA forms.
Sign PDF Documents
PDF Editor for Mac allows users to sign PDF documents with your own hand written signature or with digital signatures.
Protect PDF Files
PDF Editor for Mac allows users to protect PDF documents with passwords, certificates, or Microsoft® Rights Management Service and control what action others can perform.
Users can permanently remove (redact) visible text and images from PDFs to protect sensitive information. Allows users to apply redactions to the same position in multiple pages and to choose how to fill the redaction area with auto-resized overlay text/code. It also support search and redact.
Protect PDF with Document Sanitization
Removes sensitive information from your document before publishing, like metadata, comments, hidden data from previous saves, hidden layers, overlapping objects, and more.
Annotate PDF Files
PDF Editor for Mac allows users to provide a full set of feature-rich comment tools to mark up, annotate, and hyperlink PDF files. Summarize, import, and export comments. Create, customized, and insert stamps.
Initiate shared reviews and provide and manage comments.
Navigate by Bookmarks
PDF Editor for Mac allows users to jump to the specific section of a PDF file by bookmark. Users can also add, rename, delete bookmarks, or set destinations to bookmarks.
Section 508 Accessibility Checker
Checks accessibility of PDF files to verify if the document complies with Section 508 technology standards. PhantomPDF identifies and provides fixes for accessibility checker failed results to make the PDF file comply with Section 508 technology standards.
Enterprise-Wide Deployment
The Foxit Customization Tool helps IT professionals configure the installer prior to organization-wide deployment, and quickly install and activate Foxit PhantomPDF Mac on all the devices across your organization without any user interaction.
Get to KnowAll the Features
View Feature Table
Try PhantomPDFMac
Free For 14 Days
FindHelp
Why Use a PDF Editor?
View the 10 Reasons to use a PDF Editor.
Learn More
Which PDF Editor to Choose?
Watching this video makes this decision easy. Free klaus schulze transfer rar.
Watch now
What is PhantomPDF?
View the product demo video.
View Demo
See also: Generic ProAir RespiClick, Generic ProAir Digihaler
ProAir HFA is a brand name of albuterol, approved by the FDA in the following formulation(s):
PROAIR HFA (albuterol sulfate - aerosol, metered;inhalation)
- Manufacturer: TEVA BRANDED PHARM
Approval date: October 29, 2004
Strength(s): EQ 0.09MG BASE/INH [RLD][AB2]
Has a generic version of ProAir HFA been approved?
A generic version of ProAir HFA has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to ProAir HFA and have been approved by the FDA:
albuterol sulfate aerosol, metered;inhalation
- Manufacturer: PERRIGO PHARMS CO
Approval date: February 24, 2020
Strength(s): EQ 0.09MG BASE/INH [AB2]
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of ProAir HFA. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: Generic Drug FAQs.
Related Patents
Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.
- Dose counter for inhaler having a bore and shaft arrangement
Patent 10,022,509
Issued: July 17, 2018
Assignee(s): Ivax Pharmaceuticals IrelandNorton (Waterford) LimitedTeva Pharmaceuticals IrelandA dose counter for an inhaler, the dose counter having a display tape arranged to be incrementally driven from a tape stock bobbin onto an incremental tape take-up drive shaft, the bobbin having an internal bore supported by and for rotation about a support shaft, at least one of the bore and support shaft having a protrusion which is resiliently biased into frictional engagement with the other of the bore and support shaft with longitudinally extending mutual frictional interaction.Patent expiration dates:- May 18, 2031✓
- May 18, 2031
- Dose counters for inhalers, inhalers and methods of assembly thereof
Patent 10,022,510
Issued: July 17, 2018
Assignee(s): Ivax Pharmaeuticals IrelandNorton (Waterford) LimitedTeva Pharmaceuticals IrelandA tape system for a dose counter for an inhaler, the tape system having a main elongate tape structure, dosing indicia located on the main elongate tape structure, tape positioning indicia located on the main elongate tape structure, a tape size marker located on the main elongate tape structure indicating a number of dosing indicia on the tape, and priming indicia located on the main elongate tape structure, the priming indicia being located between the dosing indicia and one end of the tape.Patent expiration dates:- May 18, 2031✓
- May 18, 2031
- Dose counter for inhaler and method for counting doses
Patent 10,086,156
Issued: October 2, 2018
Assignee(s): Ivax Pharmaceuticals IrelandNorton (Waterford) LimitedTeva Pharmaceuticals IrelandA dose counter for a metered dose inhaler includes an incremental counting system for counting doses. The incremental counting system has a main body, an actuator arranged to be driven in response to canister motion and to drive an incremental output member in response to canister motion. The actuator and incremental output member are configured to have predetermined canister fire and count configurations in a canister fire sequence. The canister fire configuration is determined by a position of the actuator relative to a datum at which the canister fires medicament and the count configuration is determined by a position of the actuator relative to the datum at which the incremental count system makes an incremental count. The actuator is arranged to reach a position in the count configuration at or after a position in the canister fire configuration.Patent expiration dates:- May 18, 2031✓
- May 18, 2031
- Patent 10,561,808Patent expiration dates:
- January 1, 2032✓
- January 1, 2032
- Patent 10,695,512Patent expiration dates:
- May 18, 2031✓
- May 18, 2031
- Suspension aerosol formulations
Patent 7,105,152
Issued: September 12, 2006
Inventor(s): Schultz; Robert K. & Schultz; David W. & Moris; Robert A.
Assignee(s): 3M Innovative Properties CompanyPharmaceutical suspension aerosol formulations containing a therapeutically effective amount of a drug and HFC 134a, HFC 227, or a mixture thereof.Patent expiration dates:- September 12, 2023✓
- September 12, 2023
- Metered-dose inhaler
Patent 8,132,712
Issued: March 13, 2012
Inventor(s): Fenlon; Derek
Assignee(s): Ivax Pharmaceuticals IrelandA metered dose inhaler dose counter, the counter includes: an actuator; a rotary gear wheel having a plurality of ratchet teeth; a driver for driving the rotary gear in a step-wise fashion in response to displacement of the actuator; a pawl that prevents reverse rotation of the rotary gear; and a display coupled to the rotary gear.Patent expiration dates:- September 7, 2028✓
- September 7, 2028
- Dose counters for inhalers, inhalers and methods of assembly thereof
Patent 9,463,289
Issued: October 11, 2016
Assignee(s): IVAX Pharmaceuticals IrelandNorton (Waterford) LimitedTeva Pharmaceuticals IrelandA manually operated metered dose inhaler includes a dose counter chamber including a dose display tape driven by a ratchet wheel which is driven in turn by an actuator pawl actuated by movement of a canister, the tape unwinding from a stock bobbin during use of the inhaler, a rotation regulator being provided for the stock bobbin and including a wavelike engagement surface with concavities which engage against control elements in the form of protrusions on resilient forks of a split pin thereby permitting incremental unwinding of the stock bobbin yet resisting excessive rotation if the inhaler is dropped onto a hard surface.Patent expiration dates:- May 18, 2031✓
- May 18, 2031
- Patent 9,808,587Vumt 2 mac torrent. Patent expiration dates:
- May 18, 2031✓
- May 18, 2031
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
More about ProAir HFA (albuterol)
- During Pregnancy or Breastfeeding
Consumer resources
Other brands:Ventolin HFA, Ventolin, Proventil, AccuNeb, .. +5 more
Professional resources
Pronto Patent (free Version For Mac Download
Related treatment guides
Glossary
Pronto Patent (free Version For Mac Windows 7
Term | Definition |
---|---|
Drug Patent | A drug patent is assigned by the U.S. Patent and Trademark Office and assigns exclusive legal right to the patent holder to protect the proprietary chemical formulation. The patent assigns exclusive legal right to the inventor or patent holder, and may include entities such as the drug brand name, trademark, product dosage form, ingredient formulation, or manufacturing process A patent usually expires 20 years from the date of filing, but can be variable based on many factors, including development of new formulations of the original chemical, and patent infringement litigation. |
Drug Exclusivity | Exclusivity is the sole marketing rights granted by the FDA to a manufacturer upon the approval of a drug and may run simultaneously with a patent. Exclusivity periods can run from 180 days to seven years depending upon the circumstance of the exclusivity grant. |
RLD | A Reference Listed Drug (RLD) is an approved drug product to which new generic versions are compared to show that they are bioequivalent. A drug company seeking approval to market a generic equivalent must refer to the Reference Listed Drug in its Abbreviated New Drug Application (ANDA). By designating a single reference listed drug as the standard to which all generic versions must be shown to be bioequivalent, FDA hopes to avoid possible significant variations among generic drugs and their brand name counterpart. |
AB | Products meeting necessary bioequivalence requirements. Multisource drug products listed under the same heading (i.e., identical active ingredients(s), dosage form, and route(s) of administration) and having the same strength (see Therapeutic Equivalence-Related Terms, Pharmaceutical Equivalents) generally will be coded AB if a study is submitted demonstrating bioequivalence. In certain instances, a number is added to the end of the AB code to make a three character code (i.e., AB1, AB2, AB3, etc.). Three-character codes are assigned only in situations when more than one reference listed drug of the same strength has been designated under the same heading. Two or more reference listed drugs are generally selected only when there are at least two potential reference drug products which are not bioequivalent to each other. If a study is submitted that demonstrates bioequivalence to a specific listed drug product, the generic product will be given the same three-character code as the reference listed drug it was compared against. |